Kindred Bio: 3Q Earnings Snapshot

November 7, 2018

BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Wednesday reported a loss of $13 million in its third quarter.

On a per-share basis, the Burlingame, California-based company said it had a loss of 39 cents.

The biopharmaceutical company posted revenue of $640,000 in the period.

Kindred Bio shares have risen 54 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $14.59, a rise of 92 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN

Update hourly